Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

castlevax

Vaccines

Vaccines Today—January 16, 2026

This week's Vaccines update highlights recent progress across vaccines and…

Vaccines_News

Vaccines Video Recap—November 14, 2025

This biweekly video recap highlights early-phase immunogenicity and safety…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Hematology Today—February 16, 2026
Oncology Video Recap—February 16, 2026
Oncology Today—February 16, 2026
Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL

Tags

AA Signature AGC Biologics AHA Scientific Sessions AI in cardiology biotech M&A Cancer in Millennials CD19 CD19 CAR-T China licensing DPP-4 inhibitors DYNE-251 efruxifermin Enanta epigenetics ETX-636 evERA GPRC5D HGPS IVUS Kesimpta LGMD2i medical imaging MR repair nivolumab SC North Star Novo Medi Sciences Omvoh Once-monthly incretins oral GLP-1 pediatric leukemia Peripheral artery disease Pharma venture capital plixorafenib protocol-based HTN diabetes care REQORSA RhythmScience HF-AI Savara Sciwind Biosciences SR Tiget SynKIR-110 TB HEART tenosynovial giant cell tumor Tralokinumab University of Oslo YouTube Anemia

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Hematology Today—February 16, 2026
Oncology Video Recap—February 16, 2026
Oncology Today—February 16, 2026
Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal
Lucid Diligence Brief: Disc Medicine bitopertin FDA CRL

TAGS

AA Signature AGC Biologics AHA Scientific Sessions AI in cardiology biotech M&A Cancer in Millennials CD19 CD19 CAR-T China licensing DPP-4 inhibitors DYNE-251 efruxifermin Enanta epigenetics ETX-636 evERA GPRC5D HGPS IVUS Kesimpta LGMD2i medical imaging MR repair nivolumab SC North Star Novo Medi Sciences Omvoh Once-monthly incretins oral GLP-1 pediatric leukemia Peripheral artery disease Pharma venture capital plixorafenib protocol-based HTN diabetes care REQORSA RhythmScience HF-AI Savara Sciwind Biosciences SR Tiget SynKIR-110 TB HEART tenosynovial giant cell tumor Tralokinumab University of Oslo YouTube Anemia

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy